KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Times Interest Earned: 2019-2025

Historic Times Interest Earned for Royalty Pharma (RPRX) over the last 7 years, with Sep 2025 value amounting to $5.37.

  • Royalty Pharma's Times Interest Earned fell 51.43% to $5.37 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.49, marking a year-over-year decrease of 26.41%. This contributed to the annual value of $5.73 for FY2024, which is 28.10% down from last year.
  • Latest data reveals that Royalty Pharma reported Times Interest Earned of $5.37 as of Q3 2025, which was up 75.72% from $3.06 recorded in Q2 2025.
  • Over the past 5 years, Royalty Pharma's Times Interest Earned peaked at $19.90 during Q2 2021, and registered a low of -$10.28 during Q4 2022.
  • Moreover, its 3-year median value for Times Interest Earned was $5.50 (2024), whereas its average is $6.25.
  • Per our database at Business Quant, Royalty Pharma's Times Interest Earned tumbled by 414.73% in 2022 and then surged by 590.76% in 2025.
  • Royalty Pharma's Times Interest Earned (Quarterly) stood at $3.27 in 2021, then tumbled by 414.73% to -$10.28 in 2022, then soared by 226.18% to $12.97 in 2023, then tumbled by 57.61% to $5.50 in 2024, then crashed by 51.43% to $5.37 in 2025.
  • Its Times Interest Earned stands at $5.37 for Q3 2025, versus $3.06 for Q2 2025 and $8.19 for Q1 2025.